Development of Fda-Regulated Medical Products: Prescription

Description Specifications
Description
Development of Fda-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices

There have been revolutionary changes to the classification and regulation of prescription drugs, biologics, and medical devices since the previous edition of this book was published in 1997 under the title Product Development Planning for Health Care Products Regulated by the FDA. The revised book includes: a review of the significant changes within the FDA that affect the requirements and review of medical products; updated facts and figures; expansion of subjects that have grown more critical, such as clinical outcomes, human factors, and marketing objectives; and additional new topics such as the role of product development in hazard analysis, recalls, and product liability. This book is intended as a foundation for anyone involved in product development of pharmaceuticals, biologics, or medical devices. Helpful references include a glossary, acronyms, and a list of useful resources.
After reading this book, individuals involved in medical product development, regardless of their background or functional discipline, will understand all facets of the processâ€”from idea creation through to commercialization and marketing.
Specifications
Country USA
Manufacturer Asq Pr
Binding Paperback
UnitCount 1
EANs 9780873896139
ReleaseDate 0000-00-00

Devine Guidance for Complying with the FDA'S Quality System Regulation: 21 CFR, Part 820

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients

The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices

CAPA for the FDA-Regulated Industry

Biodesign: The Process of Innovating Medical Technologies

Clinical Evaluation of Medical Devices: Principles and Case Studies

Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Reference

Quality Risk Management in the FDA-Regulated Industry

Devine Guidance for Complying with the FDA'S Quality System Regulation: 21 CFR, Part 820

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients

The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices

CAPA for the FDA-Regulated Industry

Biodesign: The Process of Innovating Medical Technologies

Clinical Evaluation of Medical Devices: Principles and Case Studies

Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Reference

Quality Risk Management in the FDA-Regulated Industry

Devine Guidance for Complying with the FDA'S Quality System Regulation: 21 CFR, Part 820

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients

The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices

CAPA for the FDA-Regulated Industry

Biodesign: The Process of Innovating Medical Technologies

Clinical Evaluation of Medical Devices: Principles and Case Studies

Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Reference

Quality Risk Management in the FDA-Regulated Industry

Development of Fda-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices